Anzeige
Mehr »
Samstag, 05.07.2025 - Börsentäglich über 12.000 News
LiquidLink startet Bitcoin Lightning- und XRP-ILP-Nodes - Aufbau des Rückgrats der tokenisierten Finanzwelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
222 Leser
Artikel bewerten:
(1)

American Screening LLC CEO, Ron Kilgarlin, Reveals Many Substance Testing Kits That Use Urine or Saliva

SHREVEPORT, LA / ACCESSWIRE / October 19, 2021 / American Screening LLC has been supporting the efforts against substance abuse and addiction for about 17 years. The company's hard work was done by being the provider of a wide-ranging drug testing items. These were offered at the lowest possible prices while maintaining their quality. This has helped the Shreveport, Louisiana-based company become an ISO13485 contract manufacturer and one of the leading distributors of diagnostic products and essential medical supplies, making it a trusted partner to clinics, laboratories, medical practices, probation officers, staffing companies, and consumers. Over the years, American Screening LLC has been steadily expanding its inventory to include screening solutions for various conditions and substances, personal protective equipment (PPE), and everyday health products, but it has always remained firmly focused on stocking the best merchandise. A source of pride for the company is its extensive range of urine and saliva drug tests, which are the two most commonly administered varieties due to being the most accurate and least invasive.

American Screening LLC notes that the opioid crisis in the United States brought the problem of substance abuse into the limelight and united the nation in a fight against drug misuse. The heavy personal toll is one thing, but alcohol and drug abuse (nicotine included) costs the US economy dearly: according to the Surgeon General, it cuts the national GDP by more than $740 billion annually through crime, lost work productivity, and health care. ASC adds that reducing drug misuse and addiction requires a combination of robust preventive programs, increased public awareness, strong oversight of the prescription medicines market, and an extensive screening in all settings. The company plays an important part in the last area by ensuring that accurate and affordable tests are readily available to any interested party.

American Screening LLC offers more than 80 products in the saliva testing category, covering the range from general screening for unknown substances to identifying specific drugs. Accurate, fast, and reliable, its oral fluid kits can detect the most commonly abused substances, including alcohol, amphetamines, barbiturates, cocaine, marijuana, and opiates. Many of the products are carried at reduced prices for bulk orders, which makes American Screening LLC a great partner for large clinics and medical practices. The company is also a leading supplier of urine drug tests, offering kits that enable screening at home, in work environments, and law enforcement settings. Fast and easy to use, these tests have up to 99% accuracy in detecting a long list of illicit or commonly abused substances, among them fentanyl, oxycodone, marijuana (THC), cocaine, opiates, methamphetamine, ETG, K2, amphetamines, phencyclidine (PCP), benzodiazepine, barbiturates, methadone, tramadol, and ecstasy (MDMA). Whether looking for urine cassettes, cups, dip cards, or key cups, buyers are certain to find the right product for their needs, benefiting from attractive prices and the highest quality of customer service.

American Screening LLC is one of only a handful of companies awarded certification under the Medical Device Single Audit Program (MDSAP), which designates it as compliant with the quality management requirements of numerous jurisdictions. Established in 2004 by Ron Kilgarlin, American Screening LLC has grown from a home-based operation into one of the leading providers of diagnostic tests and medical supplies to the United States, South America, Asia, Africa, Europe, and Australia.

American Screening, LLC - Leading Provider of Diagnostic Tests & Medical Supplies: http://americanscreeningcorporationnews.com

American Screening LLC Founder, Ron Kilgarlin, on Improved Efficiency in Decision-Making with Rapid Drug Tests: https://apnews.com/article/coronavirus-pandemic-business-technology-health-4984166f0d2a716baa5137741175445b

Contact Information:
Ron Kilgarlin
American Screening, LLC
9742 St Vincent Ave, Ste 100
Shreveport, LA 71106
1-866-526-2873
sales@americansreeningcorp.com
https://www.americanscreeningcorp.com

SOURCE: American Screening LLC



View source version on accesswire.com:
https://www.accesswire.com/668678/American-Screening-LLC-CEO-Ron-Kilgarlin-Reveals-Many-Substance-Testing-Kits-That-Use-Urine-or-Saliva

© 2021 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.